HomeCompareSBBP vs STAG

SBBP vs STAG: Dividend Comparison 2026

SBBP yields 100.00% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBBP wins by $3.88M in total portfolio value
10 years
SBBP
SBBP
● Live price
100.00%
Share price
$2.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.90M
Annual income
$1,312,946.05
Full SBBP calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — SBBP vs STAG

📍 SBBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBBPSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBBP + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBBP pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBBP
Annual income on $10K today (after 15% tax)
$8,500.00/yr
After 10yr DRIP, annual income (after tax)
$1,116,004.14/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, SBBP beats the other by $1,115,611.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBBP + STAG for your $10,000?

SBBP: 50%STAG: 50%
100% STAG50/50100% SBBP
Portfolio after 10yr
$1.96M
Annual income
$656,704.13/yr
Blended yield
33.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBBP right now

SBBP
Analyst Ratings
9
Buy
2
Hold
Consensus: Buy
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBBP buys
0
STAG buys
0
No recent congressional trades found for SBBP or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBBPSTAG
Forward yield100.00%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$3.90M$18.3K
Annual income after 10y$1,312,946.05$462.22
Total dividends collected$3.48M$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: SBBP vs STAG ($10,000, DRIP)

YearSBBP PortfolioSBBP Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$20,700$10,000.00$10,665$345.09+$10.0KSBBP
2$41,495$19,345.79$11,364$357.70+$30.1KSBBP
3$80,643$36,243.16$12,098$370.43+$68.5KSBBP
4$152,116$65,828.38$12,869$383.28+$139.2KSBBP
5$278,813$116,048.53$13,677$396.23+$265.1KSBBP
6$497,119$198,789.52$14,524$409.27+$482.6KSBBP
7$863,169$331,251.38$15,411$422.41+$847.8KSBBP
8$1,461,129$537,538.09$16,339$435.61+$1.44MSBBP
9$2,413,798$850,390.15$17,311$448.89+$2.40MSBBP
10$3,895,710$1,312,946.05$18,327$462.22+$3.88MSBBP

SBBP vs STAG: Complete Analysis 2026

SBBPStock

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.

Full SBBP Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this SBBP vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBBP vs SCHDSBBP vs JEPISBBP vs OSBBP vs KOSBBP vs MAINSBBP vs PLDSBBP vs EQRSBBP vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.